Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2019-13517
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not restricted in coordination with the expiration of access based on active directory user account changes when the device is joined to an AD domain.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
会话固定
Source: NVD (National Vulnerability Database)
Vulnerability Title
BD Pyxis 授权问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
BD Pyxis是美国碧迪医疗（BD）公司的一套药物管理系统。 BD Pyxis ES 1.3.4版本至1.6.1和Pyxis Enterprise Server（Windows Server）4.4版本至4.12版本中存在授权问题漏洞。攻击者可利用该漏洞获取之前用户的访问权限，访问病人的信息及用药。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-BD Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12 -
II. Public POCs for CVE-2019-13517
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2019-13517
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same vendor: n/a
Same weakness: CWE-384
V. Comments for CVE-2019-13517

No comments yet

Leave a comment